Get started
Author

Dolgorzhap Dasheeva

Treatment Outcomes in Patients With Chronic Myeloid Leukemia According to the Russian Part of the Eutos Population-based Study
2019 · A. G. Turkina, O. V. Lazareva, et al. · Гематология и трансфузиология · 6
PDF
Observation in a treatment-free remission in chronic myeloid leukemia patients with a stable deep molecular response in the Russian portion of the international multicenter population based study EUTOS PBS
2022 · E. Yu. Chelysheva, O. V. Lazareva, et al. · Гематология и трансфузиология · 4
PDF
Quality of Life and Efficacy of Triplet IxaRd Therapy in Relapsed/Refractory Multiple Myeloma: Results of a Multi-Center Pilot Real-World Study
2022 · T. I. Ionova, O. Yu. Vinogradova, et al. · Clinical oncohematology · 2
Pb2021: Quality of Life and Clinical Outcomes in Patients With Relapsed/refractory Multiple Myeloma (rrmm) Treated With Ixazomib-lenalidomide-dexamethasone (ird): Results of a Real-world Evidence Study
2022 · T. Ionova, O. Vinogradova, et al. · HemaSphere · 1
The 15 Year Long-Term Survival of Patients with Chronic Myeloid Leukaemia from 35 Regions of Russian Federation: A Follow up of a Multicenter Observation Study Eutos Osp Initiated By European Leukemia NET
2021 · Olga V. Lazareva, Ekaterina Yu. Chelysheva, et al. · Blood
Quality of Life (QoL) and Clinical Outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Ixazomib-Lenalidomide-Dexamethasone (IRd) in a Real-World Setting
2020 · Tatyana Ionova, Elena Ado, et al. · Blood
On a Long Way to the Treatment Free Remisson: The Results of the Long-Term Observation of the Chronic Myeloid Leukemia Patients in Russian Part of EUTOS Population-Based Study
2019 · Olga V. Lazareva, Ekaterina Yu. Chelysheva, et al. · Blood
Works count: 8
Citation count: 13
H-index: 2
I10-index:
Year
Topic
Type